Pharmadule presents radical biopharma construction vision at ManuBio 2014

Pharmadule presents radical biopharma construction vision at ManuBio 2014

Pharmadule Morimatsu Logo 150 x 48

Press Release | Pharmadule Morimatsu AB

JUNE 03, 2014

Boston, MA: – Organizers of this month’s ManuBio summit for biomanufacturing decision makers have confirmed that Scott Kaplan, Senior Director of Project Development at Pharmadule Morimatsu Inc., has joined the list of keynote speakers.

Mr. Kaplan’s address will build on a recent magazine article to show how adopting more integrated and modular approaches to designing and constructing biotech facilities can play key roles in combating the threat of pipeline attrition caused by inefficiencies and failure to meet regulatory standards.

His company is the US arm of Swedish-based Pharmadule Morimatsu AB, designer and builder of modular production facilities for the pharma and biopharma industries.

“I will demonstrate how flexible designs and adaptable solutions can support the more holistic view of the project lifecycle that ManuBio is keen to promote,” said Mr. Kaplan.

“In particular, I aim to show the summit some radical new solutions that leverage the advantages of single-use process equipment, modular design and off-site fabrication, thus streamlining the delivery process while enhancing predictability and mitigating risk,” he said.

Pharmadule will also be exhibiting its design technologies and turnkey solutions at the event in Boston, starting June 10.

Large-molecule shift

“A major theme of the conference will be that the shift in emphasis towards large-molecule drugs has led to an industry shift towards biologic development with which laboratory development and manufacturing are still struggling to keep pace,” said Mr. Kaplan.

“We all know that airtight biopharmaceutical production facilities are essential if the new investment in LMD development is really to reap its due rewards. The revolutionary types of modular design and off-site construction methodologies we have pioneered in Sweden can help to make that vision become reality,” he commented.

“This is Pharmadule’s first appearance at the ManuBio summit and we’re looking forward to the chance to exchanging information about trends in our industry, finding out about new projects and meeting the key decision makers in the many companies who could benefit from our knowhow and services,” added Mr. Kaplan.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities for the pharma and biopharma Industries. Pharmadule engineering and design services extend from conceptual design to IQ/OQ completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance and Validation Management.

The company was founded in 1986, since then it has successfully delivered more than 60 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in the USA and Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.

About ManuBio 2014

The ManuBio Leaders Summit USA (ManuBio) is a key annual meeting for leading biomanufacturing professionals, industry innovators and strategists. ManuBio USA’s mission is to bridge the knowledge gap between upstream productivity and downstream processes, in order to encourage excellence in biomanufacturing and overcome challenges in cost, volume and efficiency.

The event attracts some 150 delegates, primarily from the USA but with significant contingents from Europe, Asia and EMEA. The event is organised by GBX Summits.

The 2014 summit will be held on June 10-11 at the Revere Hotel in Boston, Massachusetts. It will feature an exhibition, some 40 presentations and four workshops covering topics including upstream and downstream process development, operational excellence strategies and implementing QbD quality by design.

Media Contact

Maria Rosén, Marketing Director, Pharmadule Morimatsu AB
Tel: +46 70 750 0036



Click on Pharmadule presents radical biopharma construction vision at ManuBio 2014 for other information.
Click on Pharmadule to contact the company directly.

Supplier Information
Supplier: Pharmadule Morimatsu AB
Address: DanvikCenter 28, SE – 131 30 Nacka, Sweden
Tel: +46 (0)8 587 42 000

Comments are closed.